Actinium Pharmaceuticals (ATNM) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATNM is expected to report earnings to fall 1.18% to -33 cents per share on November 14

Actinium Pharmaceuticals ATNM Stock Earnings Reports

Q3'24

Est.

$-0.34

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.06

Q4'23

Beat

by $0.23

Q3'23

Est.

$-0.49

The last earnings report on July 29 showed earnings per share of -34 cents, beating the estimate of -38 cents. With 233.62K shares outstanding, the current market capitalization sits at 51.47M.

View a ticker or compare two or three

Compare

ATNM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ATNM
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

100 Park Avenue

Phone

+1 646 677-3870

Employees

Web

https://www.actiniumpharma.com